Science is in the nature of cooperation. Many consortia and alliances in scientific fields exceed language boundaries and barriers. Some laboratories can be able to find additional funds from alternative sources, such as the European Union. But it is unlikely that the continuous withdrawal of NIH financing can be connected by foreign support. According to the sources she talked to, which she talked to, with seemingly endless funds, with seemingly endless funds.
“This cannot be conveyed to pharmaceutical or biotechnology because they are not interested in things that are as pre -clinical as many works we discuss here,” says a professor of genetics, who agreed to speak anonymously fear of revenge. “Basically, there is a whole legion of university scientists who work hard to try to come up with basic things that ultimately become something that a pharmaceutical company can reduce $ 100 million.”
Millions of dollars granted to laboratory with high achievement are used to finance students, laboratory technology and analysts. If the main researcher of the research team does not happen to obtain a subsidy through the process described by Keusch, often the laboratory is closed, and these helpful members of the team lose their jobs.
One of the potential further effects of the loss of NIH financing, even if only momentary, is mass brain drainage. “Many of these people intend to find something different,” says the genetics professor. “They are like work for everything else – we can’t pay people for a month. What would the gastronomy industry look like, for example or grocery stores if they don’t pay someone for a month? Their employees will leave and Pharma can only employ so many people. “
Wired heard over and over again, from scientists too terrifying, so that their teams and their tasks speak on the album, that it would not last long to reach the general population. Along with the loss of research financing, hospitals and universities are closed. And profits from medical progress will probably also fall.
The conditions studied when financing NIH are not only infrequent diseases affecting 1 or 2 percent of the population. These are problems such as cancer, diabetes, Alzheimer’s disease – issues that affect your grandmother, friends and so many people who one day will fall out of perfect health. It is thanks to this research system and scientists working in it. Doctors know how to save someone from a heart attack, regulate diabetes, lower cholesterol and reduce the risk of stroke. In this way, the world knows that smoking is not a good idea. “All this is the knowledge that scientists financed by Nih generated, and if you throw this key at it, it will disturb absolutely everything,” says the professor of genetics.
While some hope that the freezing of academic resources can end on February 1, when the retention of communication, and therefore the reviews of the subsidy are to boost, the people she talked to are largely skeptical, that the work will simply resume as before.